Transformation and tumor progression are frequently associated with expression of the α3/β1 heterodimer in solid tumors
✍ Scribed by Armando Bartolazzi; Cristina Cerboni; Maria R. Nicotra; Marcella Mottolese; Aldo Bigotti; Pier G. Natali
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- French
- Weight
- 536 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
The ability of tumor cells to interact with the extracellular matrix (ECM) is functionally mediated by a variety of receptor molecules among which the integrins are a well-characterized family of mediators. In this study we have investigated irnmunohistochemically the in vivo expression of the a,/Pl promiscuous receptor for ECM constituents in a variety of human solid malignancies. Although the receptor appears to undergo changes in distribution patterns, its expression is maintained in a high percentage of primary (76%) and metastatic (82%) tumors. Furthermore, the comparative immunohistochemical evaluation of a 3 / P I and its ligands, in a selected number of tumors of different histotypes, demonstrated that the expression of this integrin correlates with the presence of at least one ligand, either around nests of neoplastic cells or at the epithelialstromal interface. The highly conserved expression of a3lPI
shown in this study suggests that this receptor may play a role in tumor growth at the primary as well as at the metastatic site.
📜 SIMILAR VOLUMES
## Abstract Hypoxia‐inducible factor (HIF)‐1α is a key nuclear transcription factor that regulates the cellular response to hypoxia, and is important for solid tumor growth and survival. However, the underlying role of HIF‐1α in human chondrosarcoma has not been well characterized. This study aims
## Background: Transforming growth factor-beta1 (tgf-beta1) acts as a potent inhibitor of cell growth and tumor progression but loss of this negative regulation can contribute to tumor development. some studies have reported an association between disease progression and tgf-beta1 expression in pat
## Abstract ## Objective To determine whether cytokine gene polymorphisms of interferon‐γ (IFNγ), interleukin‐6 (IL‐6), IL‐10, tumor necrosis factor α (TNFα), and transforming growth factor β1 (TGFβ1) predispose subjects to the development of primary Sjögren's syndrome (SS). ## Methods Single‐ba